eIF5A/eIF5A2 rabbit pAb
ENT-A13542
Description
| REF | ENT-A13542 |
|---|---|
| Category | Antibody Polyclonal |
| Description | eIF5A/eIF5A2 rabbit pAb |
| Source | Rabbit |
| Applications | WB; ELISA |
| Reactivity | Human; Mouse; Rat |
| Reactivity | Human; Mouse; Rat |
| Dilution | WB 1:500-2000, ELISA(peptide)1:5000-20000 |
| Immunogen | Synthesized peptide derived from human eIF5A/eIF5A2 |
| Storage Stability | -20°C/1 year |
| Clonality | Polyclonal |
| Isotype | IgG |
| Concentration | 1 mg/ml |
| Observed Band KD | 17kD |
| Human Gene ID | 1984 |
| Human Swiss Prot Nº | P63241/Q9GZV4 |
| Subcellular Location | Cytoplasm . Nucleus . Endoplasmic reticulum membrane ; Peripheral membrane protein ; Cytoplasmic side . Hypusine modification promotes the nuclear export and cytoplasmic localization and there was a dynamic shift in the localization from predominantly cytoplasmic to primarily nuclear under apoptotic inducing conditions (PubMed:19379712, PubMed:27306458). Nuclear export of hypusinated protein is mediated by XPO4 (PubMed:10944119, PubMed:27306458). . |
Other Name: Eukaryotic translation initiation factor 5A-1 (eIF-5A-1;eIF-5A1;Eukaryotic initiation factor 5A isoform 1;eIF-5A;Rev-binding factor;eIF-4D)
Background:
